Rally Research

Dr. Mark Chiang’s Discovery Paves the Way for Acute Leukemia Treatment without Major Side Effects

Tags: , |

Dr. Mark Chiang Through his work at the University of Michigan Cancer Center, Rally Researcher Dr. Mark Chiang discovered a novel protein that sticks to a leukemia cancer gene called Notch. This discovery could potentially pave the way for anti-Notch drugs—drugs without the harsh, harmful side effects of traditional acute leukemia treatment. We

Unraveling the Mystery Behind JMML Outcomes

Rally-funded researcher helps to identify predictors for JMML patient outcomes. Rally’s early support of Dr. Elliot Stieglitz’ career may have changed the future for children who will be diagnosed with juvenile myelomonocytic leukemia (JMML), a type of blood cancer sometimes caused by a mutation present at birth. Rally Researcher Dr. Elliot Stieglitz Each

Rally Research in Action

My passion is to better understand the genetic basis of leukemia in order to develop better therapies. My laboratory specializes in studying the link between Down syndrome and leukemia, because these children have a high rate of cancer: they are at a 500-fold increased risk of a rare subtype of myeloid leukemia and a 20-fold

The Impact of Rally Research

The Impact of Rally Research - Dr. Simone Sredni Like so many people, I have pictures on my desk: pictures of my husband and of my kids. However, I also have pictures of children that I do not personally know. These pictures inspire me in my search for a cure for a rare, yet very